KEY FEATURES
| Full Name | Intercellular Adhesion Molecule 4 |
|---|---|
| Synonym | CD242; LW; Landsteiner-Weiner Blood System; Landsteiner-Wiener blood group glycoprotein |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.15-10ng/mL |
| Sensitivity | 0.07ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human ICAM4 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human ICAM4. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human ICAM4 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human ICAM4, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human ICAM4. You can calculate the concentration of Human ICAM4 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human ICAM4 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.55 | 1.28 | 3.9 | 0.57 | 1.34 | 3.61 |
| Standard deviation | 0.03 | 0.05 | 0.18 | 0.04 | 0.07 | 0.18 |
| CV(%) | 5.16 | 4.15 | 4.52 | 6.47 | 4.87 | 5.04 |
RECOVERY
The recovery of Human ICAM4 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 96-111 | 102 |
| EDTA plasma (n=8) | 91-106 | 97 |
| Cell culture media (n=8) | 87-98 | 93 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human ICAM4 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with IFI44 ELISA Kits
| MX1 ELISA Kit | publications with IFI44 and MX1 |
| IFIT1 ELISA Kit | publications with IFI44 and IFIT1 |
| IFI44L ELISA Kit | publications with IFI44 and IFI44L |
| IFIT3 ELISA Kit | publications with IFI44 and IFIT3 |
| RSAD2 ELISA Kit | publications with IFI44 and RSAD2 |
| ISG15 ELISA Kit | publications with IFI44 and ISG15 |
| IFIT2 ELISA Kit | publications with IFI44 and IFIT2 |
| IFIH1 ELISA Kit | publications with IFI44 and IFIH1 |
| XAF1 ELISA Kit | publications with IFI44 and XAF1 |
| OASL ELISA Kit | publications with IFI44 and OASL |
Diseases associated with IFI44 ELISA Kit
| Liver Diseases | publications with IFI44 and Liver Diseases |
| Neoplasms | publications with IFI44 and Neoplasms |
| Inflammation | publications with IFI44 and Inflammation |
| Disease Models, Animal | publications with IFI44 and Disease Models, Animal |
| Necrosis | publications with IFI44 and Necrosis |
| Neurobehavioral Manifestations | publications with IFI44 and Neurobehavioral Manifestations |
| Lung Neoplasms | publications with IFI44 and Lung Neoplasms |
| Congenital Abnormalities | publications with IFI44 and Congenital Abnormalities |
| Neoplasms, Experimental | publications with IFI44 and Neoplasms, Experimental |
| Kidney Diseases | publications with IFI44 and Kidney Diseases |
Organs/Tissues associated with IFI44 ELISA Kit
| Blood | publications with IFI44 and Blood |
| Liver | publications with IFI44 and Liver |
| Brain | publications with IFI44 and Brain |
| Kidney | publications with IFI44 and Kidney |
| Eye | publications with IFI44 and Eye |
| Thymus | publications with IFI44 and Thymus |
| Salivary Gland | publications with IFI44 and Salivary Gland |
| Mouth | publications with IFI44 and Mouth |
| Skin | publications with IFI44 and Skin |
| Lung | publications with IFI44 and Lung |